Valsartan contraindications
Pro Research Analysisby
Searched over 200M research papers for "valsartan contraindications"
Valsartan Contraindications: Key Insights from Recent Research
Introduction to Valsartan
Valsartan is an antihypertensive medication that belongs to the class of angiotensin II receptor antagonists. It is primarily used to manage high blood pressure and heart failure by inhibiting the effects of angiotensin II, a hormone that can constrict blood vessels and increase blood pressure.
Contraindications in Pregnancy and Renal Artery Stenosis
One of the primary contraindications for valsartan is its use during pregnancy. Valsartan, like other angiotensin II receptor blockers (ARBs), can cause harm to the developing fetus and is therefore contraindicated in pregnant women. Additionally, patients with renal artery stenosis should avoid valsartan, as it can exacerbate renal impairment.
Kidney Function and Valsartan Use
Patients with severe kidney impairment, specifically those with an estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m², are generally advised against using valsartan. This is due to the increased risk of adverse effects such as hyperkalemia and worsening renal function. However, some studies suggest that valsartan can still be beneficial in heart failure patients with advanced chronic kidney disease (CKD), provided they are closely monitored.
Valsartan in Heart Failure and Drug Interactions
Valsartan is effective in reducing morbidity and mortality in patients with chronic heart failure. However, caution is advised when it is used in combination with other heart failure medications, such as ACE inhibitors and beta-blockers. Studies have shown that while valsartan can improve clinical outcomes, it may have adverse effects when combined with both ACE inhibitors and beta-blockers, potentially increasing the risk of mortality and morbidity.
Conclusion
Valsartan is a valuable medication for managing hypertension and heart failure, but it comes with specific contraindications. It should not be used during pregnancy or in patients with renal artery stenosis. Additionally, its use in patients with severe kidney impairment should be carefully considered and monitored. When used in combination with other heart failure medications, the potential for adverse interactions must be taken into account to ensure patient safety.
Sources and full results
Most relevant research papers on this topic